Taro to Release Third Quarter Results on January 25, 2024

Rhea-AI Summary

Taro Pharmaceutical Industries Ltd. (TARO) is set to release its financial results for the third quarter ended December 31, 2023, on January 25, 2024. The release will be available on Taro's website, www.taro.com.

HAWTHORNE, N.Y.--(BUSINESS WIRE)-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the third quarter ended December 31, 2023, after the close of market on Thursday, January 25, 2024.

The release will be accessible on Taro’s website at www.taro.com.

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240119038585/en/

William J. Coote

VP, Chief Financial Officer

(914) 345-9001

William.Coote@taro.com

Source: Taro Pharmaceutical Industries Ltd.

FAQ

When will Taro Pharmaceutical Industries Ltd. release its financial results for the third quarter of 2023?

Taro Pharmaceutical Industries Ltd. (TARO) will release its financial results for the third quarter ended December 31, 2023, after the close of market on Thursday, January 25, 2024.

Where can I access Taro Pharmaceutical Industries Ltd.'s financial results release?

The release will be accessible on Taro’s website at www.taro.com.